Generalized Anxiety Disorder Clinical Trial
Official title:
The Efficacy of a Video-based Transdiagnostic REBT Universal Prevention Program Delivered in a School Context for Internalizing Problems in Adolescents
Verified date | February 2023 |
Source | Babes-Bolyai University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Anxiety and depressive disorders are common in adolescents, however they are often unrecognized. Rational emotive behavioral therapy (REBT), a form of cognitive behavioral therapy (CBT) is efficient for children and adolescents. School settings are appropriate environments to deliver such interventions for vulnerable youths. Given youth's access and predilection to use technology, a video-based prevention program was developed. The present study aims to investigate the efficacy of a transdiagnostic REBT prevention program for internalizing symptoms in adolescents, implemented in a school setting. Classes from different Romanian public schools will be randomized in either intervention or wait list group.
Status | Completed |
Enrollment | 381 |
Est. completion date | June 2018 |
Est. primary completion date | June 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 12 Years to 17 Years |
Eligibility | Inclusion Criteria: 1. Preadolescents and adolescents will have ages between 12 and 17 years old; 2. Are attending middle school or high-school; 3. Adolescents have sufficient understanding of the Romanian language in order to complete assessments at all time points and to participate in the prevention program; 4. Their parents have sufficient understanding of the Romanian language in order to sign the informed consent; 5. Parents will sign the informed consent and adolescents will provide informed assent. Exclusion Criteria: 1. Age below 14 or above 17 years; 2. No signed informed consent from parents; 3. Adolescents will score high on suicidal ideation according to (1 item on the Depression subscale from Beck Youth Inventories); 4. Not Romanian-speaking in order to understand the content of the prevention program and to complete the assessments. |
Country | Name | City | State |
---|---|---|---|
Romania | Babes-Bolyai University | Cluj-Napoca |
Lead Sponsor | Collaborator |
---|---|
Babes-Bolyai University |
Romania,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The Multidimensional Anxiety Scale for Children (MASC; March, Parker, Sullivan, Stallings, & Conners, 1997) | anxiety symptoms | Change from baseline anxiety symptoms at 3 weeks post-intervention, 3 months follow up, 12 months follow-up | |
Primary | Beck Depression Inventory for Youth subscale from the Beck Youth Inventories-Second edition for children and adolescents (Beck, 2005) | depressive symptoms | Change from baseline depressive symptoms at 3 weeks post-intervention, 3 months follow up, 12 months follow-up | |
Secondary | The Children's Automatic Thoughts Scale - Negative/Positive (CATS-N/P) (Hogendoorn et al., 2010) | maladaptive cognitions | Change from baseline maladaptive cognitions at 3 weeks post-intervention, 3 month follow up, 12 months follow-up | |
Secondary | The Strengths and Difficulties Questionnaire (SDQ) (Goodman, 1997) | comorbid problems | Change from baseline comorbid problems at 3 weeks post-intervention, 3 months follow up, 12 months follow-up | |
Secondary | The Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents, The Revised Version - adolescent version (Kiddo-KINDL) (Ravens-Sieberer et al., 2001) | quality of life | Change from baseline quality of life at 3 weeks post-intervention, 3 months follow up, 12 months follow-up | |
Secondary | The Credibility/ Expectancy Questionnaire (Devilly & Borkovec, 2000) | Treatment expectancies | pre-intervention | |
Secondary | The Client Satisfaction Scale (Vigerland et al., 2016) | Satisfaction with the intervention | post-intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03420456 -
Transcranial Pulse Near-Infrared Light in Generalized Anxiety Disorder: a Placebo-Controlled Study
|
N/A | |
Active, not recruiting |
NCT05530642 -
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
|
N/A | |
Withdrawn |
NCT02382224 -
Worry Exposure for Generalized Anxiety Disorder
|
N/A | |
Completed |
NCT02256566 -
Cognitive Training for Mood and Anxiety Disorders
|
N/A | |
Completed |
NCT02306356 -
Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting
|
N/A | |
Completed |
NCT01958788 -
Testing Beliefs About Uncertainty in the Treatment of Generalized Anxiety Disorder
|
N/A | |
Completed |
NCT01681329 -
Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Disorder
|
N/A | |
Completed |
NCT01201967 -
A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients
|
Phase 4 | |
Completed |
NCT01337713 -
Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD)
|
N/A | |
Completed |
NCT01342120 -
PHARMO Institute Seroquel Safety Study
|
N/A | |
Completed |
NCT01971203 -
Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat
|
N/A | |
Completed |
NCT00961298 -
An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder
|
Phase 4 | |
Completed |
NCT01203293 -
Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector
|
Phase 1 | |
Completed |
NCT00744627 -
Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.
|
Phase 3 | |
Terminated |
NCT01244711 -
Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
|
Phase 4 | |
Completed |
NCT00711737 -
Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
|
N/A | |
Completed |
NCT00537615 -
An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers
|
Phase 1 | |
Completed |
NCT00525226 -
Evaluating the Effects of Stress in Pregnancy
|
N/A | |
Completed |
NCT00515242 -
Therapeutic Massage for Generalized Anxiety Disorder
|
Phase 1/Phase 2 | |
Completed |
NCT00368745 -
Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use.
|
Phase 3 |